ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $1,243,000 | -45.2% | 30,755 | -21.9% | 0.00% | -40.0% |
Q2 2015 | $2,268,000 | -2.0% | 39,398 | +8.4% | 0.01% | +25.0% |
Q1 2015 | $2,315,000 | +484.6% | 36,354 | +466.5% | 0.00% | +300.0% |
Q4 2014 | $396,000 | -5.0% | 6,417 | -47.0% | 0.00% | 0.0% |
Q2 2014 | $417,000 | – | 12,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |